Cargando…
Mutations of epigenetic regulatory genes are common in thymic carcinomas
Genetic alterations and etiology of thymic epithelial tumors (TETs) are largely unknown, hampering the development of effective targeted therapies for patients with TETs. Here TETs of advanced-stage patients enrolled in a clinical trial of molecularly-guided targeted therapies were employed for targ...
Autores principales: | Wang, Yisong, Thomas, Anish, Lau, Christopher, Rajan, Arun, Zhu, Yuelin, Killian, J. Keith, Petrini, Iacopo, Pham, Trung, Morrow, Betsy, Zhong, Xiaogang, Meltzer, Paul S., Giaccone, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258655/ https://www.ncbi.nlm.nih.gov/pubmed/25482724 http://dx.doi.org/10.1038/srep07336 |
Ejemplares similares
-
Whole Genome and Transcriptome Sequencing of a B3 Thymoma
por: Petrini, Iacopo, et al.
Publicado: (2013) -
Novel Treatments for Thymoma and Thymic Carcinoma
por: Rajan, Arun, et al.
Publicado: (2015) -
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors
por: Petrini, I, et al.
Publicado: (2012) -
Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations
por: Petrini, Iacopo, et al.
Publicado: (2022) -
Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape
por: Chorro, Laurent, et al.
Publicado: (2018)